 Connection
Paul Bunn to Animals
This is a "connection" page, showing publications Paul Bunn has written about Animals.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.354 |
|
|
|
-
Helfrich BA, Kim J, Gao D, Chan DC, Zhang Z, Tan AC, Bunn PA. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Mol Cancer Ther. 2016 10; 15(10):2314-2322.
Score: 0.031
-
Bunn PA, Minna JD, Augustyn A, Gazdar AF, Ouadah Y, Krasnow MA, Berns A, Brambilla E, Rekhtman N, Massion PP, Niederst M, Peifer M, Yokota J, Govindan R, Poirier JT, Byers LA, Wynes MW, McFadden DG, MacPherson D, Hann CL, Farago AF, Dive C, Teicher BA, Peacock CD, Johnson JE, Cobb MH, Wendel HG, Spigel D, Sage J, Yang P, Pietanza MC, Krug LM, Heymach J, Ujhazy P, Zhou C, Goto K, Dowlati A, Christensen CL, Park K, Einhorn LH, Edelman MJ, Giaccone G, Gerber DE, Salgia R, Owonikoko T, Malik S, Karachaliou N, Gandara DR, Slotman BJ, Blackhall F, Goss G, Thomas R, Rudin CM, Hirsch FR. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? J Thorac Oncol. 2016 Apr; 11(4):453-74.
Score: 0.030
-
Bunn PA. Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch Pathol Lab Med. 2012 Dec; 136(12):1478-81.
Score: 0.024
-
Doebele RC, Oton AB, Peled N, Camidge DR, Bunn PA. New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer. Lung Cancer. 2010 Jul; 69(1):1-12.
Score: 0.020
-
Helfrich BA, Raben D, Varella-Garcia M, Gustafson D, Chan DC, Bemis L, Coldren C, Bar?n A, Zeng C, Franklin WA, Hirsch FR, Gazdar A, Minna J, Bunn PA. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. Clin Cancer Res. 2006 Dec 01; 12(23):7117-25.
Score: 0.016
-
Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W, Bar?n AE, Zeng C, Johnson TK, Bunn PA. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):795-805.
Score: 0.014
-
Raben D, Bianco C, Damiano V, Bianco R, Melisi D, Mignogna C, D'Armiento FP, Cionini L, Bianco AR, Tortora G, Ciardiello F, Bunn P. Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. Mol Cancer Ther. 2004 Aug; 3(8):977-83.
Score: 0.014
-
Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May; 8(5):1280-7.
Score: 0.012
-
Chan DC, Earle KA, Zhao TL, Helfrich B, Zeng C, Baron A, Whitehead CM, Piazza G, Pamukcu R, Thompson WJ, Alila H, Nelson P, Bunn PA. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res. 2002 Mar; 8(3):904-12.
Score: 0.011
-
Raben D, Helfrich BA, Chan D, Johnson G, Bunn PA. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol. 2002 Feb; 29(1 Suppl 4):37-46.
Score: 0.011
-
Bunn PA, Chan DC, Earle K, Zhao TL, Helfrich B, Kelly K, Piazza G, Whitehead CM, Pamukcu R, Thompson W, Alila H. Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer. Semin Oncol. 2002 Feb; 29(1 Suppl 4):87-94.
Score: 0.011
-
Stewart JM, Gera L, York EJ, Chan DC, Bunn P. Bradykinin antagonists: present progress and future prospects. Immunopharmacology. 1999 Sep; 43(2-3):155-61.
Score: 0.010
-
Bunn PA. Immune therapy for lung cancer: are we getting closer? Am J Respir Cell Mol Biol. 1999 Jul; 21(1):10-2.
Score: 0.010
-
Wang Y, Jiang T, Qin Z, Jiang J, Wang Q, Yang S, Rivard C, Gao G, Ng TL, Tu MM, Yu H, Ji H, Zhou C, Ren S, Zhang J, Bunn P, Doebele RC, Camidge DR, Hirsch FR. HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. Ann Oncol. 2019 03 01; 30(3):447-455.
Score: 0.009
-
Bunn PA, Helfrich BA, Brenner DG, Chan DC, Dykes DJ, Cohen AJ, Miller YE. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. Clin Cancer Res. 1998 Nov; 4(11):2849-58.
Score: 0.009
-
Leonard SC, Lee H, Gaddy DF, Klinz SG, Paz N, Kalra AV, Drummond DC, Chan DC, Bunn PA, Fitzgerald JB, Hendriks BS. Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer. Anticancer Drugs. 2017 11; 28(10):1086-1096.
Score: 0.008
-
Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017 12; 17(12):725-737.
Score: 0.008
-
Bunn PA. The emerging role of gemcitabine in lung cancer: part I. Semin Oncol. 1997 Apr; 24(2 Suppl 7):S7-1.
Score: 0.008
-
Scarborough HA, Helfrich BA, Cas?s-Selves M, Schuller AG, Grosskurth SE, Kim J, Tan AC, Chan DC, Zhang Z, Zaberezhnyy V, Bunn PA, DeGregori J. AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition. Clin Cancer Res. 2017 Mar 15; 23(6):1531-1541.
Score: 0.008
-
Suda K, Bunn PA, Rivard CJ, Mitsudomi T, Hirsch FR. Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal?from the Bench. J Thorac Oncol. 2017 01; 12(1):27-35.
Score: 0.008
-
Cas?s-Selves M, Kim J, Zhang Z, Helfrich BA, Gao D, Porter CC, Scarborough HA, Bunn PA, Chan DC, Tan AC, DeGregori J. Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition. Cancer Res. 2012 Aug 15; 72(16):4154-64.
Score: 0.006
-
Longley C, Furmanski P, Dienhart DG, Lear J, Bloedow D, Kasliwal R, Bunn PA. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. Cancer Res. 1990 Sep 15; 50(18):5954-61.
Score: 0.005
-
Bunn PA, Dienhart DG, Chan D, Puck TT, Tagawa M, Jewett PB, Braunschweiger E. Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways. Proc Natl Acad Sci U S A. 1990 Mar; 87(6):2162-6.
Score: 0.005
-
Frederick BA, Helfrich BA, Coldren CD, Zheng D, Chan D, Bunn PA, Raben D. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol Cancer Ther. 2007 Jun; 6(6):1683-91.
Score: 0.004
-
Lynch TJ, Adjei AA, Bunn PA, Eisen TG, Engelman J, Goss GD, Haber DA, Heymach JV, J?nne PA, Johnson BE, Johnson DH, Lilenbaum RC, Meyerson M, Sandler AB, Sequist LV, Settleman J, Wong KK, Hart CS. Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4365s-4371s.
Score: 0.004
-
Lindmo T, Bunn PA. Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling. Methods Enzymol. 1986; 121:678-91.
Score: 0.004
-
Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, Baron AE, Keith RL, Nemenoff RA, Malkinson AM, Geraci MW. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 2005 Dec; 167(6):1763-75.
Score: 0.004
-
Stewart JM, Gera L, Chan DC, York EJ, Simkeviciene V, Bunn PA, Taraseviciene-Stewart L. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists. Peptides. 2005 Aug; 26(8):1288-91.
Score: 0.004
-
Bunn PA, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ, Blattner W, Broder S, Robert-Guroff M, Gallo RC. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983 Aug 04; 309(5):257-64.
Score: 0.003
-
Whitehead CM, Earle KA, Fetter J, Xu S, Hartman T, Chan DC, Zhao TL, Piazza G, Klein-Szanto AJ, Pamukcu R, Alila H, Bunn PA, Thompson WJ. Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival. Mol Cancer Ther. 2003 May; 2(5):479-88.
Score: 0.003
-
Stewart JM, Chan DC, Simkeviciene V, Bunn PA, Helfrich B, York EJ, Taraseviciene-Stewart L, Bironaite D, Gera L. Bradykinin antagonists as new drugs for prostate cancer. Int Immunopharmacol. 2002 Dec; 2(13-14):1781-6.
Score: 0.003
-
Stewart JM, Gera L, Chan DC, Bunn PA, York EJ, Simkeviciene V, Helfrich B. Bradykinin-related compounds as new drugs for cancer and inflammation. Can J Physiol Pharmacol. 2002 Apr; 80(4):275-80.
Score: 0.003
-
Stewart JM, Gera L, York EJ, Chan DC, Whalley EJ, Bunn PA, Vavrek RJ. Metabolism-resistant bradykinin antagonists: development and applications. Biol Chem. 2001 Jan; 382(1):37-41.
Score: 0.003
-
Agus DB, Bunn PA, Franklin W, Garcia M, Ozols RF. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer. Semin Oncol. 2000 Dec; 27(6 Suppl 11):53-63; discussion 92-100.
Score: 0.003
-
Gazdar AF, Carney DN, Russell EK, Schechter GP, Bunn PA. In vitro growth of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):587-90.
Score: 0.002
-
Bunn PA, Shackney SE, Ford SS. The effects of colcemid on hematopoiesis in the mouse. J Clin Invest. 1976 Nov; 58(5):1280-5.
Score: 0.002
-
Heasley LE, Zamarripa J, Storey B, Helfrich B, Mitchell FM, Bunn PA, Johnson GL. Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase-deficient G alpha 16. J Biol Chem. 1996 Jan 05; 271(1):349-54.
Score: 0.002
-
Franklin WA, Waintrub M, Edwards D, Christensen K, Prendegrast P, Woods J, Bunn PA, Kolhouse JF. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer Suppl. 1994; 8:89-95.
Score: 0.002
-
Bunn PA, Okamoto M, Riker WF. Further observations on subacute denervation and mammalian motor nerve terminal function. Neurology. 1973 Jan; 23(1):12-20.
Score: 0.002
-
Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res. 1992 Sep 01; 52(17):4752-7.
Score: 0.001
-
Mulvin DW, Howard RB, Mitchell DH, Noker PE, Kruse CA, Chu HD, Bunn PA, Johnston MR. Secondary screening system for preclinical testing of human lung cancer therapies. J Natl Cancer Inst. 1992 Jan 01; 84(1):31-7.
Score: 0.001
-
Gonzalez R, Salem P, Bunn PA, Zukiwski AA, Lamb R, Benjamin RS, Spitler L, Wedel N, Robinson WA. Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial. Mol Biother. 1991 Dec; 3(4):192-6.
Score: 0.001
-
Howard RB, Chu H, Zeligman BE, Marcell T, Bunn PA, McLemore TL, Mulvin DW, Cowen ME, Johnston MR. Irradiated nude rat model for orthotopic human lung cancers. Cancer Res. 1991 Jun 15; 51(12):3274-80.
Score: 0.001
-
Doyle LA, Cuttitta F, Mulshine JL, Bunn PA, Minna JD. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells. Cancer Res. 1987 Oct 01; 47(19):5009-13.
Score: 0.001
-
Mulshine JL, Keenan AM, Carrasquillo JA, Walsh T, Linnoila RI, Holton OD, Harwell J, Larson SM, Bunn PA, Weinstein JN. Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging. Cancer Res. 1987 Jul 01; 47(13):3572-6.
Score: 0.001
-
Carrasquillo JA, Mulshine JL, Bunn PA, Reynolds JC, Foon KA, Schroff RW, Perentesis P, Steis RG, Keenan AM, Horowitz M, et al. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J Nucl Med. 1987 Mar; 28(3):281-7.
Score: 0.001
-
Broder S, Bunn PA, Jaffe ES, Blattner W, Gallo RC, Wong-Staal F, Waldmann TA, DeVita VT. NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med. 1984 Apr; 100(4):543-57.
Score: 0.001
-
Mitsuya H, Matis LA, Megson M, Bunn PA, Murray C, Mann DL, Gallo RC, Broder S. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J Exp Med. 1983 Sep 01; 158(3):994-9.
Score: 0.001
-
BUNN PA, KNIGHT R. Alteration in chronic staphylococcal furunculosis by use of gamma globulin. N Y State J Med. 1962 Dec 15; 62:3899-907.
Score: 0.001
-
BALTCH AL, OSBORNE W, CANARILE L, HASSIRDJIAN A, BUNN PA. Serum properdin, complement and agglutinin changes in dogs with staphylococcal bacteremia. J Immunol. 1962 Mar; 88:361-8.
Score: 0.001
-
Carney DN, Gazdar AF, Bunn PA, Guccion JG. Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells (1981). 1982; 1(3):149-64.
Score: 0.001
-
Carney DN, Bunn PA, Gazdar AF, Pagan JA, Minna JD. Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci U S A. 1981 May; 78(5):3185-9.
Score: 0.001
-
Gazdar AF, Carney DN, Russell EK, Sims HL, Baylin SB, Bunn PA, Guccion JG, Minna JD. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 1980 Oct; 40(10):3502-7.
Score: 0.001
-
Levine RF, Bunn PA, Hazzard KC, Schlam ML. Flow cytometric analysis of megakaryocyte ploidy. Comparison with Feulgen microdensitometry and discovery that 8N is the predominant ploidy class in guinea pig and monkey marrow. Blood. 1980 Aug; 56(2):210-17.
Score: 0.001
-
Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980 Mar; 55(3):409-17.
Score: 0.001
-
BUNN P, ROBINSON F. Relative efficacies of chick embryo and standard American Trudeau Society medium in isolation of tubercle bacilli from human sputum. Am Rev Tuberc. 1957 Oct; 76(4):703-5.
Score: 0.001
-
Shackney SE, Bunn PA, Ford SS. The effects of colcemid on mouse bone marrow. Cell Tissue Kinet. 1976 Jul; 9(4):363-9.
Score: 0.000
-
BUNN PA, ROBINSON F, OSBORNE W. Use of chick embryo as medium for rapid cultivation of tubercle bacilli. J Lab Clin Med. 1955 Apr; 45(4):658-60.
Score: 0.000
-
BUNN P, ROBINSON F. The use of the rabbit eye as a tissue to study tuberculosis. IV. Effect of therapy with streptomycin-isoniazid and with growth hormone (STH) upon the course of the infection. Am Rev Tuberc. 1954 Jun; 69(6):1016-21.
Score: 0.000
-
BUNN P, ROBINSON FO. Effects of decreasing dosages of corticotropin upon the course of ocular tuberculosis in the rabbit. Am Rev Tuberc. 1954 Jun; 69(6):1051-3.
Score: 0.000
-
BUNN PA, ROBINSON F. The use of the rabbit eye to study tuberculosis: the effect of adrenocorticotropin, growth hormone, and a combination of isonicotinic acid hydrazide with streptomycin upon the course of the disease. Trans Annu Meet Natl Tuberc Assoc. 1953; 49:212-3.
Score: 0.000
-
BUNN P, DROBECK B. Use of rabbit eye as a tissue to study tuberculosis. III. Effect of adrenal hormones upon course of disease and upon certain immunologic responses. Am Rev Tuberc. 1952 Aug; 66(2):175-87.
Score: 0.000
-
BUNN P, DROBECK B, GINO J, ADAIR C. Some observations upon the Middlebrook-Dubos hemagglutination test in man and animals. Ann Intern Med. 1952 Jul; 37(1):84-95.
Score: 0.000
-
BUNN PA. Effect of adrenal hormones upon course of ocular tuberculosis and upon certain immunologic responses in the rabbit. Trans Annu Meet Natl Tuberc Assoc. 1952; 48:406-7.
Score: 0.000
-
BUNN PA, DROBECK B. Use of rabbit eye as a tissue to study tuberculosis. I. Development of localized ocular lesion. Am Rev Tuberc. 1951 Aug; 64(2):197-206.
Score: 0.000
-
ADAIR CV, DROBECK B, BUNN PA. Use of rabbit eye as a tissue to study tuberculosis. II. Effect of certain antituberculous agents upon ocular tuberculosis. Am Rev Tuberc. 1951 Aug; 64(2):207-17.
Score: 0.000
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|